PRESS RELEASE published on 02/14/2025 at 12:28, 1 year 1 month ago Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates Moderna, Inc. reports Q4 revenues of $1.0B with a net loss of $(1.1)B. Forecasts 2025 revenue of $1.5-2.5B. Submitted 3 mRNA products for regulatory approval. Financial details and pipeline updates disclosed Revenues Net Loss Moderna MRNA Products 2025 Revenue
BRIEF published on 01/29/2025 at 13:05, 1 year 1 month ago Moderna to Announce Financial Results for Q4 and 2024 Financial Results Webcast Corporate Update MRNA Technology Moderna
PRESS RELEASE published on 01/29/2025 at 13:00, 1 year 1 month ago Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025 Moderna, Inc. to host conference call on February 14, 2025 to report Q4 and full year 2024 financial results, and provide a corporate update. Details on webcast available on Moderna website Financial Results Conference Call Webcast Moderna Inc. MRNA Medicine
BRIEF published on 01/24/2025 at 12:35, 1 year 1 month ago Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
PRESS RELEASE published on 01/24/2025 at 12:30, 1 year 1 month ago Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union Moderna awarded tender to supply mRNA COVID-19 vaccine in EU, Norway, and North Macedonia, offering diverse formats like prefilled syringes. Enhancing vaccination campaigns with efficient options COVID-19 Moderna MRNA Vaccine Vaccination Campaigns Prefilled Syringes
BRIEF published on 01/17/2025 at 22:33, 1 year 2 months ago Moderna Advances mRNA-Based Influenza Vaccine Development Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE published on 01/17/2025 at 22:28, 1 year 2 months ago Moderna Announces Updates on Pandemic Influenza Program Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF published on 01/13/2025 at 13:05, 1 year 2 months ago Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
PRESS RELEASE published on 01/13/2025 at 13:00, 1 year 2 months ago Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF published on 11/25/2024 at 13:05, 1 year 3 months ago Moderna to Present at December 2024 Investor Conferences Investor Conferences Healthcare Webcast MRNA Technology Moderna
Published on 03/18/2026 at 19:05, 39 minutes ago Deposit Modeling at Thor Shows that the Proven Thor Epithermal Deposit is Flanked on Both Sides by a Much Larger Deposit
Published on 03/18/2026 at 18:10, 1 hour 34 minutes ago Silver X Mining Closes C$69M Brokered Private Placement of Secured Convertible Debentures
Published on 03/18/2026 at 14:30, 5 hours 14 minutes ago Ground Geophysics Underway at Murphy Lake, 5 km From Isoenergy's Hurricane Deposit, Athabasca Basin
Published on 03/18/2026 at 14:15, 5 hours 29 minutes ago Apex Provides Phase I Drilling Update at the Rift Rare Earth Project in Nebraska, U.S.A.
Published on 03/18/2026 at 14:00, 5 hours 44 minutes ago Route1 Announces Filing of Parking Copilot Patent Application and Confirms Expected Launch Date for "Mr. Parking"
Published on 03/18/2026 at 18:53, 51 minutes ago EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
Published on 03/18/2026 at 18:37, 1 hour 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/18/2026 at 18:15, 1 hour 29 minutes ago Northern Data Group releases audited FY 2025 Financial Results
Published on 03/18/2026 at 17:43, 2 hours 1 minute ago Voluntary public takeover bid by B&C Holding Österreich GmbH for Semperit Aktiengesellschaft Holding
Published on 03/18/2026 at 18:00, 1 hour 44 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
Published on 03/18/2026 at 17:45, 1 hour 59 minutes ago Infotel : 2025 full-year results. Launch of a new Infotel 2030 strategic plan. Revenue target of €500 million by 2030.
Published on 03/18/2026 at 07:00, 12 hours 44 minutes ago Mersen: A resilient performance in 2025, return to growth expected in 2026